Skip to main content
. 2021 Mar 2;9(3):2325967120973284. doi: 10.1177/2325967120973284

TABLE A2.

Meta-regression P Valuesa

Characteristic Outcome
Pain Function
PRP category .629 .547
Spinning approach .075 .153
Activator .549 .098
No. of injections .565 .249
Randomization confirmed .642 .795
Allocation concealment confirmed .832 .818
Sufficient blinding .394 .407
Control group .033; .147b .217
Outcome measure instrument .921 NA
Follow-up duration .058 .228

aNA, not applicable; PRP, platelet-rich plasma.

bP value for meta-analysis restricted to high-quality trials.